Skip to content
Home  /  AMC CAT  /  Study notes  /  Hypertension - diagnosis, targets, stepped pharmacotherapy, secondary causes

Hypertension - diagnosis, targets, stepped pharmacotherapy, secondary causes

● AMC CAT LO AMC_SYS_05LO AMC_KU_03LO AMC_KU_04LO AMC_KU_05LO AMC_KU_07LO AMC_SK_13LO AMC_SK_16LO AMC_SK_17LO AMC_SK_18LO AMC_SK_19 1,815 words
Free preview. This study note covers 10 learning objectives (AMC_SYS_05, AMC_KU_03, AMC_KU_04, AMC_KU_05, AMC_KU_07, AMC_SK_13, AMC_SK_16, AMC_SK_17, AMC_SK_18, AMC_SK_19) from the AMC CAT curriculum. Inside PRIMEX you get exam-style MCQ practice on this topic, an OSCE simulator covering all six AMC Part 2 station types, Ask PRIMEX for Australian-context clinical questions, and a curriculum tracker mapped to every blueprint patient group.

1. Definition and clinical relevance

Hypertension is a sustained elevation of arterial blood pressure that, over time, drives cardiovascular, cerebrovascular and renal disease.

A disease of ageing:

Continuous variable, not a threshold:

Part of comprehensive cardiovascular risk reduction:

Why it matters:

2. Key values, thresholds and decision rules

Measurement technique

Diagnostic thresholds

Category Clinic BP (mmHg)
High-normal 130-139 and/or 85-89
Grade 1 (mild) hypertension 140-159 and/or 90-99
Grade 2 (moderate) hypertension 160-179 and/or 100-109
Grade 3 (severe) hypertension ≥180 and/or ≥110
Isolated systolic hypertension >140 and <90

When systolic and diastolic fall into different categories, the higher category applies.

Out-of-clinic method Hypertension threshold (mmHg)
ABPM daytime (awake) ≥135 and/or ≥85
ABPM night-time (asleep) ≥120 and/or ≥70
ABPM over 24 hours ≥130 and/or ≥80
HBPM ≥135 and/or ≥85

Who to treat with drugs

Situation Decision rule
Known CVD (prior MI, stroke or TIA, peripheral arterial disease, heart failure) Secondary prevention; the CVD risk calculator is not used
Grade 3 hypertension (≥180/110 mmHg) Above the very-high-BP threshold (>160/100 mmHg): BP-lowering therapy is warranted regardless of calculated risk
5-year CVD risk ≥10% on the Aus CVD Risk Calculator, or clinically determined high risk (moderate to severe CKD, familial hypercholesterolaemia) Prescribe BP-lowering pharmacotherapy
Intermediate risk (5% to <10%) Consider BP-lowering pharmacotherapy after discussing benefits and harms
Low risk (<5%) Pharmacotherapy not routinely recommended; BP >160/100 mmHg warrants BP-lowering therapy

Targets: treat uncomplicated hypertension to <140/90 mmHg, or lower if tolerated (<140/90 mmHg also in diabetes and CKD; in CKD, aiming towards systolic <120 mmHg has shown benefit where well tolerated, and in diabetes a systolic target of <120 mmHg may be considered where stroke prevention is prioritised). In selected high cardiovascular risk patients, including well-tolerated patients >75 years without diabetes, a systolic target of <120 mmHg can improve outcomes, with close follow-up for hypotension, syncope, electrolyte abnormalities and acute kidney injury.

Adding and adjusting therapy

Cardiovascular co-therapy

3. Approach: presentation and differential

History

Hypertension is usually asymptomatic and found on screening. Take a targeted history covering:

Features that raise the probability of a secondary cause and warrant a lower threshold for investigation include age under 35 (especially without a family history), accelerated or malignant hypertension, and hypokalaemia.

Examination

Differential

Consider the causes of secondary hypertension (5-10% of cases):

4. Investigations

Bedside

Bloods

Imaging

5. Management

Step 1: Lifestyle and population measures

Step 2: Drug therapy

Step 3: Special populations

Step 4: Failure to respond / referral

Blood pressure in hospital

Inpatient BP readings require careful interpretation and management, and acute severe hypertension should be handled according to the clinical context rather than treated reflexively against a single reading.

6. Australian-specific considerations

Clinical pearls

PRIMEX

Practice this topic in the app

Work through MCQs on this exact LO, run an OSCE station that maps to AMC_SYS_05, AMC_KU_03, AMC_KU_04, AMC_KU_05, AMC_KU_07, AMC_SK_13, AMC_SK_16, AMC_SK_17, AMC_SK_18, AMC_SK_19, or ask PRIMEX a clinical question framed for the AMC. Your free trial covers all 26 exams.

Start 7-day free trial

7-day free trial · Cancel anytime

Quick recall flashcards

A small sample of the deck for this topic. Tap a question to reveal the answer. The full deck and spaced-repetition scheduler live inside PRIMEX.

How many follow-up measurements are required before diagnosing hypertension, and what out-of-office method is preferred to confirm the diagnosis?

At least two follow-up measurements are required. Ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) is preferred to exclude white coat hypertension.

What clinic BP threshold defines hypertension (Grade 1) in the Australian guideline, and what are the corresponding daytime ABPM and HBPM thresholds?

Clinic BP of 140/90 mmHg or above (Grade 1, mild: 140-159 and/or 90-99 mmHg); the daytime (awake) ABPM and HBPM thresholds are both 135/85 mmHg or above.

What clinic BP ranges define Grade 2 and Grade 3 hypertension, and what are the 24-hour and night-time ABPM thresholds for hypertension?

Grade 2 (moderate) is 160-179 and/or 100-109 mmHg; Grade 3 (severe) is ≥180 and/or ≥110 mmHg. On ABPM, hypertension is ≥130/80 mmHg over 24 hours and ≥120/70 mmHg at night (asleep).

At what clinic systolic BP level is hypertension classified as severe?

Severe hypertension is defined by a clinic systolic BP of 180 mmHg or above (or markedly elevated clinic diastolic BP).

Start free trial→